Onderneming Xenon Pharmaceuticals Inc.
Aandelen
XENE
CA98420N1050
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
40,5 USD | +1,00% | +1,55% | -12,07% |
Vakgebied
Aantal werknemers: 255
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ian Mortimer
CEO | Chief Executive Officer | 48 | 21-10-13 |
Simon Pimstone
FOU | Founder | 56 | 05-11-96 |
Sherry Aulin
DFI | Director of Finance/CFO | 40 | 01-01-11 |
Chief Tech/Sci/R&D Officer | - | 23-08-21 | |
Sheila M. Grant
CTO | Chief Tech/Sci/R&D Officer | - | 01-08-20 |
Jodi Regts
IRO | Public Communications Contact | - | 01-12-15 |
Corporate Officer/Principal | - | 17-08-20 | |
Andrea DiFabio
LAW | General Counsel | 55 | 07-11-22 |
James Empfield
PRN | Corporate Officer/Principal | - | 01-02-16 |
Corporate Officer/Principal | 63 | 01-03-01 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Clarence Machado
BRD | Director/Board Member | 60 | 05-11-20 |
Mohammad Azab
BRD | Director/Board Member | 68 | 01-10-03 |
Justin Gover
BRD | Director/Board Member | 53 | 08-08-23 |
Gary Patou
BRD | Director/Board Member | 65 | 01-01-04 |
Simon Pimstone
FOU | Founder | 56 | 05-11-96 |
Steven Gannon
BRD | Director/Board Member | 62 | 21-05-15 |
Ian Mortimer
CEO | Chief Executive Officer | 48 | 21-10-13 |
Dawn Svoronos
BRD | Director/Board Member | 70 | 27-09-16 |
Director/Board Member | 66 | 03-06-21 | |
Gillian Cannon
BRD | Director/Board Member | 60 | 08-08-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 75 432 482 | 74 047 334 ( 98,16 %) | 0 | 98,16 % |
Bedrijfsgegevens
Xenon Pharmaceuticals, Inc.
3650 Gilmore Way Suite 200
V5G 4W8, Burnaby
+604 484 3300
http://www.xenon-pharma.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-12,07% | 3,06 mld. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |
- Beurs
- Aandelen
- Koers XENE
- Onderneming Xenon Pharmaceuticals Inc.